Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
FDA—75 years later
  • Published Date:
    Nov 1981
  • Source:
    Public Health Rep. 96(6):i2
  • Language:
    English
Filetype[PDF-371.49 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. CDC health update regarding treatment of patients with influenza with antiviral medications
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 9, 2015
    Series:
    HAN ; 375
    Description:
    January 9, 2015, 11:00 ETCDCHAN-00375As a follow-up to HAN 00374 (http://emergency.cdc.gov/han/han00374.asp, Dec. 3, 2014), CDC is providing 1) a summary of influenza antiviral drug treatment recommendations, 2) an update about approved treatment dru...
    File Type:
    Filetype[PDF - 233.96 KB]
  2. Legal Regulation of Sodium Consumption to Reduce Chronic Conditions
    Personal Author:
    Hodge, James G.; Barraza, Leila F.;
    Published Date:
    Feb 18 2016
    Source:
    Prev Chronic Dis. 13.
    Description:
    In the United States, tens of thousands of Americans die each year of heart disease, stroke, or other chronic conditions tied to hypertension from long-term overconsumption of sodium compounds. Major strides to lower dietary sodium have been made ove...
    File Type:
    Filetype[PDF - 204.68 KB]
  3. Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry
    Personal Author:
    Stockmann, Chris; Spigarelli, Michael G; Ampofo, Krow; Sherwin, Catherine MT;
    Published Date:
    Nov 04 2013
    Source:
    J Bioequivalence Bioavailab. 5:244-247
    Description:
    Drug development is an expensive process that is marked by a high-failure rate. For this reason early stage bioequivalence and pharmacokinetic studies are essential in determining the fate of new drug products. In this study, we sought to systematica...
    File Type:
    Filetype[PDF - 470.52 KB]
  4. Seasonal influenza A (H3N2) activity and antiviral treatment of patients with influenza
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    December 27, 2017
    Series:
    HAN ; 409
    Description:
    December 27, 2017, 1030 ET (10:30 AM ET)CDCHAN-00409The Centers for Disease Control and Prevention (CDC) is providing: 1) a notice about increased influenza A(H3N2) activity and its clinical implications; 2) a summary of influenza antiviral drug trea...
    File Type:
    Filetype[PDF - 511.47 KB]
  5. Diarrhetic Shellfish Poisoning, Washington, USA, 2011
    Personal Author:
    Lloyd, Jennifer K.; Duchin, Jeffrey S.; Borchert, Jerry; Quintana, Harold Flores; Robertson, Alison;
    Published Date:
    Aug 2013
    Source:
    Emerg Infect Dis. 19(8):1314-1316.
    Description:
    Diarrhetic shellfish poisoning is a gastrointestinal illness caused by consumption of bivalves contaminated with dinophysistoxins. We report an illness cluster in the United States in which toxins were confirmed in shellfish from a commercial harvest...
    File Type:
    Filetype[PDF - 322.46 KB]